Status | Study |
Terminated |
Study Name: Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm Condition: Pupillary Occlusion Date: 2012-12-31 |
Terminated |
Study Name: Acetyl Hexapeptide-8 for Blepharospasm Condition: Focal Dystonia Date: 2012-12-12 Interventions: Drug: Topical acetyl hexapeptide-8 Drug: P |
Completed |
Study Name: Blepharospasm Patient Survey for Patients With Blepharospasm Condition: Blepharospasm Date: 2012-09-12 Interventions: Other: No intervention- only one time survey |
Completed |
Study Name: Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm Condition: Blepharospasm Hemifacial Spasm Date: 2012-02-16 Interventions: Drug: Zinc Supplement The inte |
Completed |
Study Name: Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States Condition: Cervical Dystonia Blepharospasm Date: 2011-01-28 Interventions: Biological: Xeomin® Xeomin® (incobotulinumtoxinA) at a dose determined by the physician based |
Completed |
Study Name: Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm Condition: Essential Blepharospasm Date: 2010-11-25 Interventions: Drug: Botulinum Toxin Type A 2 times, Intra-muscular injection, Maximum dosage total 60U |
Completed |
Study Name: A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm Condition: Focal Dystonia Date: 2009-07-18 Interventions: Drug: Acetyl-Hexapeptide Topical Treatment |
Completed |
Study Name: Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm Condition: Blepharospasm Date: 2008-09-25 Interventions: Biological: Botulinum Toxin Type A 900kDa |
Completed |
Study Name: Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm Condition: Blepharospasm Date: 2008-05-20 Interventions: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection Each vial of Botox and KbtxA contained 1 |
Terminated |
Study Name: Blepharospasm Short Interval Condition: Blepharospasm Date: 2007-07-25 Interventions: Drug: NT 201 Injection of up to 50 Units NT 201 (incobotulinumtoxinA/Xeomin®) per eye and injection |